Shashi Sharma

Center for Food Safety and Applied Nutrition

Papers

Total Citations

H-Index

About

Dr. Shashi Sharma is a leading authority in biodefense and neurotoxin research, with a primary focus on the detection and therapeutic application of botulinum neurotoxin (BoNT). Her seminal work, including the highly cited 2012 paper "Botulinum neurotoxin: Where are we with detection technologies?" (64 citations), critically addresses the dual-use challenge of BoNT—balancing its threat as a potential biological warfare agent with its remarkable therapeutic value for neurological disorders. Dr. Sharma has pioneered advanced detection platforms that enhance global biosafety, while also advancing the clinical use of BoNT serotypes A and B for conditions like dystonia and spasticity. Her research bridges critical gaps between toxicology, public health, and clinical neurology, earning her recognition as a key contributor to both biosecurity and neurotherapeutics. With a career dedicated to mitigating risks and maximizing benefits of potent neurotoxins, Dr. Sharma’s work continues to inform policy, safeguard populations, and improve patient outcomes worldwide.